Dr. Mihir Kanitkar, MD

Dr. Kanitkar practices at Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL.

Dr. Kanitkar's NPI, 1487831566, was assigned on January 30, 2008. Dr. Kanitkar holds Alabama license 33656.

Dr. Kanitkar's primary practice is Huntsville Hospital, at 101 Sivley Rd, Huntsville, AL 35801 in Madison County. The practice phone is (256) 265-1000.

Dr. Kanitkar's primary practice is Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL. Dr. Kanitkar is also affiliated with Crestwood Medical Center. The medical group on file is The Heart Center. Dmand AI also links Dr. Kanitkar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanitkar practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kanitkar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kanitkar is licensed in Alabama.

CMS data shows 5,549 Medicare services from Dr. Kanitkar across 33 procedure codes in 2024, for 2,823 Medicare patients. Medicare paid $168,637 for them.

CMS counts 2,823 Medicare patients who saw Dr. Kanitkar in 2024. The largest group is 75 to 84, with 1,121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanitkar's median patient age at 72, with 52% women.

In 2024, Dr. Kanitkar wrote 3,265 Medicare Part D claims for 502 patients. 77% of them were for generic drugs. CMS names the drug for 3,076 of them, across 38 drugs with 11 or more claims each, at $662,091 in total drug cost. In 2023, CMS named 2,822 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kanitkar for performance year 2024, reported through an alternative payment model (APM). Dr. Kanitkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Kanitkar, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Kanitkar, published from 2013 to 2021. 2013 was the busiest year, with 2. The most frequent topics are Coronary Artery Disease, Drug-Eluting Stents and Dual Anti-Platelet Therapy. Dr. Kanitkar has published most often in Ann Thorac Surg. Dr. Kanitkar's most frequent co-authors are Robert A. Guyton, MD, Vasilis C. Babaliaros, MD and Tom C. Nguyen, MD.

Dmand AI links Dr. Kanitkar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Foramen Ovale, Patent and Heart Septal Defects, Atrial.

CMS Open Payments shows 366 general payments to Dr. Kanitkar from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Edwards Lifesciences Corporation paid the most, $6,949.